Basecamp Research is a London-based AI biotechnology company that trains frontier models for therapeutic design on BaseData, a proprietary evolutionary genomic dataset of more than 100 billion novel genes gathered across all seven continents. Its 28-billion-parameter model, EDEN, translates that data into gene insertion, gene editing and peptide therapeutics now advancing through preclinical development.
Advance EDEN-designed programs through preclinical development
Potential expansion of pharma partnerships
Basecamp Research has raised a $140 million Series C, valuing the AI drug discovery company near $1 billion, as CEO Glen Gowers outlined a six-program pipeline guided by its EDEN model.
Co-Founder and Chief Executive Officer
Co-Founder